Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
N Engl J Med. 2016 Dec 29;375(26):2561-9. doi: 10.1056/NEJMoa1610497.
N Engl J Med. 2016.
PMID: 28029927
Free PMC article.
Clinical Trial.